2m 2m 2m 2m 2m 2m 2m
ENTERA (ENTX)
NASDAQ
$1.22$0.00 (0.00%)
Price as of Jun 03, 2026 6:02 PM EDT- $24.8MMarket Cap
- -40.49%1-Year Change
- BiotechnologyIndustry
ENTERA (ENTX)
$1.22$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 42,000 -76.80% | 181,000 N/A | 0 -100.00% | 134,000 -76.53% | |
Cost of Revenue | 42,000 -75.58% | 172,000 N/A | 0 -100.00% | 101,000 -72.92% | |
Gross Profit | 0 -100.00% | 9,000 N/A | 0 -100.00% | 33,000 -83.33% | |
Sales and Marketing Expense | 398,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -6.0M +33.45% | -4.5M -0.24% | -4.5M -22.88% | -5.8M -13.63% | |
Depreciation and Amortization Expense | 30,000 -34.78% | 46,000 -17.86% | 56,000 -12.50% | 64,000 +20.75% | |
Total Operating Expenses | 11.5M +20.17% | 9.6M +7.91% | 8.9M -31.87% | 13.1M +5.11% | |
Operating Profit | -11.5M +20.28% | -9.6M +7.81% | -8.9M -31.70% | -13.0M +6.55% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 90,000 +55.17% | 58,000 +87.10% | 31,000 -62.65% | 83,000 +386.21% | |
Income before Taxes | -11.4M +20.07% | -9.5M +7.53% | -8.9M -31.50% | -12.9M +5.62% | |
Income Taxes | 0 -100.00% | 14,000 -51.72% | 29,000 -78.83% | 137,000 +332.20% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.4M +19.89% | -9.5M +7.33% | -8.9M -31.99% | -13.1M +7.25% | |
Net Income from Continuing Operations Applicable to Common | -11.4M +20.07% | -9.5M +7.53% | -8.9M -31.50% | -12.9M +5.62% | |
Basic EPS and Net Income | 0.25 0.00% | 0.25 -19.35% | 0.31 -31.11% | 0.45 -4.26% | |
Diluted EPS and Net Income | 0.25 0.00% | 0.25 -19.35% | 0.31 -31.11% | 0.45 -4.26% | |
Basic Weighted Average Shares | 46.2M +22.68% | 37.7M +29.79% | 29.0M +0.69% | 28.8M +10.23% | |
Diluted Weighted Average Shares | 46.2M +22.68% | 37.7M +29.79% | 29.0M +0.69% | 28.8M +10.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.1M -17.92% | 8.7M -21.41% | 11.0M -10.48% | 12.3M -50.55% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.1M -17.92% | 8.7M -21.41% | 11.0M -10.48% | 12.3M -50.55% | |
Total Current Assets | 15.3M +70.51% | 9.0M -20.30% | 11.3M -12.39% | 12.8M -49.27% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 134,000 +135.09% | 57,000 -43.00% | 100,000 -28.06% | 139,000 -10.90% | |
Total Long-Term Assets | 695,000 +66.27% | 418,000 -17.72% | 508,000 +82.73% | 278,000 -57.75% | |
Total Assets | 16.0M +70.32% | 9.4M -20.19% | 11.8M -10.38% | 13.1M -49.49% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.2M +87.33% | 1.2M +7.79% | 1.1M -18.64% | 1.3M -57.58% | |
Total Long-Term Debt | 295,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 689,000 +414.18% | 134,000 -53.47% | 288,000 +800.00% | 32,000 -87.74% | |
Total Liabilities | 2.9M +120.76% | 1.3M -5.00% | 1.4M +0.44% | 1.4M -59.88% | |
Retained Earnings | -125.4M +10.04% | -113.9M +9.14% | -104.4M +9.31% | -95.5M +15.86% | |
Total Stockholders Equity | 13.1M +62.14% | 8.1M -22.20% | 10.4M -11.64% | 11.8M -47.91% | |
Total Shares Outstanding | 46.2M +18.90% | 38.8M +9.47% | 35.5M +23.14% | 28.8M +0.02% | |
Cash Flow | |||||
Cash from Operating Activities | -7.4M +8.10% | -6.8M -6.73% | -7.3M -41.52% | -12.5M +37.91% | |
Capital Expenditures | 107,000 +3,466.67% | 3,000 -82.35% | 17,000 -63.83% | 47,000 +176.47% | |
Cash from Investing Activities | -107,000 +3,466.67% | -3,000 -82.35% | -17,000 -83.33% | -102,000 +500.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 13.7M +206.30% | 4.5M -25.84% | 6.0M +46,330.77% | 13,000 -99.95% | |
Financials Ratio | |||||
Gross Margin | 0.00% -100.00% | 4.97% N/A | N/A N/A | 24.63% -28.98% | |
Operating Margin | -27,450.00% +418.36% | -5,295.58% N/A | N/A N/A | -9,714.18% +354.02% | |
Return on Assets | -90.13% -0.08% | -90.20% +26.30% | -71.42% +6.86% | -66.84% -0.60% | |
Return on Equity | -108.01% +4.53% | -103.34% +28.69% | -80.30% +5.41% | -76.17% -8.65% | |
Revenue Growth | -76.80% N/A | N/A N/A | -100.00% +30.66% | -76.53% -235.60% | |
Current Ratio | 6.94 -8.98% | 7.63 -26.06% | 10.32 +7.69% | 9.58 +19.58% | |
Cash Ratio | 3.23 -56.18% | 7.36 -27.09% | 10.10 +10.03% | 9.18 +16.56% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow